Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

(2021) Dan Turner et al.   GASTROENTEROLOGY

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

(2020) Aurélien Amiot et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients after Initiation of Biologics: A Cohort Study

(2020) George Khoudari et al.   Clinical Gastroenterology and Hepatology

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

(2020) William J Sandborn et al.   INFLAMMATORY BOWEL DISEASES

Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn’s Disease: A Multicentre Study

(2020) Mathurin Fumery et al.   Journal of Crohns & Colitis

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

(2019) Aurelien Amiot et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence

(2019) Tal Engel et al.   DIGESTIVE AND LIVER DISEASE

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review

(2018) Marin J. de Jong et al.   Clinical Gastroenterology and Hepatology

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

(2018) Mathurin Fumery et al.   Clinical Gastroenterology and Hepatology

Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: a Systematic Review and Meta-analysis

(2018) Laurent Peyrin-Biroulet et al.   Clinical Gastroenterology and Hepatology

Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience

(2018) Lieven Pouillon et al.   INFLAMMATORY BOWEL DISEASES

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

(2017) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

(2016) E. J. Mao et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

(2013) Simon P.L. Travis et al.   GASTROENTEROLOGY

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

(2012) Christina Ha et al.   Clinical Gastroenterology and Hepatology